Defining Adolescent Nausea Through Brain Imaging and Neurostimulation Response

NACompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

April 23, 2018

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Functional Gastrointestinal Disorders
Interventions
DEVICE

Active Auricular Neurostimulation

Active auricular neurostimulation for 4 weeks. Subjects in Active group who do not have significant improvement after 4 weeks may receive an additional 4 weeks of active neurostimulation therapy.

DEVICE

Sham Auricular Neurostimulation

"Sham auricular neurostimulation for 4 weeks with identical device as the active but lacking the electrical charge.~Subjects in Sham group who do not have significant improvement after 4 weeks may receive an additional 4 weeks of active neurostimulation therapy."

Trial Locations (1)

53226

Children's Hospital of Wisconsin, Milwaukee

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Medical College of Wisconsin

OTHER

NCT03675321 - Defining Adolescent Nausea Through Brain Imaging and Neurostimulation Response | Biotech Hunter | Biotech Hunter